ACADEMIC POSITIONS

National and international institutions he has been a member of:

Turkish Society of Nuclear Medicine

European Association of Nuclear Medicine

Society of Nuclear Medicine

New York Academy of Sciences

Responsibilities

Board member

Turkish Society of Nuclear Medicine

1998-2000, 2000-2002, 2002-2004, 2004-2006, 2006-2008

Other Positions and Participations:

• Scientific article referee as thyroid diseases and radionuclide therapy specialist of European Journal of Nuclear Medicine and Molecular Imaging. 

 “Consultants’ meeting on introducing safe and efficacious applications of Nuclear Medicine for the treatment of cancer.” 

• International Atomic Energy Agency (IAEA), Vienna, 6 – 10 March 2006. 

In this meeting, IAEA guide book is prepared together with 6 specialists and application principles of radioiodine treatment of thyroid cancer and hyperthyroid is prepared.  

• 5 conferences and practical trainings for international participants at International Atomic Energy Agency Technical Cooperation Project, Regional Training Course on Radionuclide Treatment of Liver Cancers Seminar. Islamabad, Pakistan, October 2005. 
• 5 conferences and practical trainings for international participants at International Atomic Energy Agency Technical Cooperation Project, Regional Training Course on Pediatric Nuclear Medicine Seminar. Amman, Jordan, September 2004. 

• 5 conferences and practical trainings for international participants at International Atomic Energy Agency Technical Cooperation Project, Regional Training Course on Nuclear Oncology Seminar. United Arab Emirates, December 2003. 
• Society of Nuclear Medicine Congress, Continuing Medical Education Conference ‘Review of Recent Literature on the Radiation Protection Measures in Radionuclide Therapy: I-131 and Others’. New Orleans, USA, 2003. 
• European Society of Paediatric Urology, ESPU, 2002, Course. Conference named ‘Tc-99m EC versus Tc-99m MAG3’ at the organization on Antenatally Diagnosed Hydronephrosis: Pre- and Postnatal Assessment and Clinical Approach. Bodrum, May 2002. 
• 5 conferences and practical trainings for international participants at International Atomic Energy Agency Technical Cooperation Project, Regional Training Course on Radionuclide Applications of Infection and Inflammation Seminar. Syria, September 2002. 
• 4 conferences and practical trainings for International Academic Energy Agency Technical Cooperation Project, Pediatric Nuclear Medicine Education Seminar. Tunisia, April 2001. 

• Duty as an expert for the determination of the Improvement Framework of Nuclear Medicine and Health, together with Senegal Government Representatives in behalf of United Nations and International Atomic Energy Agency. Senegal, October 2000. 
• Radioactive Iodine Therapy at 15th National Nuclear Medicine Congress. 
• European Association of Nuclear Medicine, Pediatric Task Committee Member and Pediatric Nuclear Medicine Applications European Union application guidelines preparation committee member.  
• Seminar named ‘Pediatric Thyroid Cancer’ at Vienna Congress of European Association of Nuclear Medicine. Vienna, 2002. 
• Turkish Society of Nuclear Medicine, Endocrinology and Radionuclide Therapy Work Group Chairman. 

• “Nükleer Tıp” Turkish Journal of Nuclear Medicine journal editor. 1998 – 2004. 
• ‘World Journal of Nuclear Medicine’ editorial board member. 
• Scientific article referee at ‘Journal of Nuclear Medicine’. 
• European Association of Nuclear Medicine, Pediatric Task Committee member. 
• International Atomic Energy Agency, International Coordinated Research Project, Turkish Participant as a Chief Scientific Investigator. Multinational prospective research contract of two years named ‘Evaluation of Tc-99m Based Radiopharmaceuticals in the Diagnosis and Management of Breast Cancer Patients’. 

• International Atomic Energy Agency, International Coordinated Research Project, Turkish Participant. Multinational prospective research contract of two years named ‘Prospective Investigation of GER and Recurrent Bronchial Asthma and Pulmonary Infections’. 
• International Atomic Energy Agency, International Coordinated Research Project, Turkish Participant. Multinational prospective research contract named ‘Comparative Evaluation of Ictal Brain SPECT, Magnetic Resonance Imaging (MRI) and X-ray Computed Tomography (CT) of Brain in the Management of Patients with Refractory Seizures’. 
• Research named ‘Dynamic Renal Phantom’ within Istanbul University Research Fund, Normal Projects. 
• One year of prospective research named ‘The Relationship Between Thyroid Lesions P-gp Levels and Tc-99m Sestamibi Uptake’, research project named ‘Histopathologic Examination of the Effects of Iodine-131 Which is Used by Treatment Purposes on Salivary Glands and Oral Mucosa (Experimental Research on Rabbits)’ within Istanbul University Research Fund, Normal Projects, speech named ‘TC-99m Sestamibi Scintimammography for the Differential Diagnosis of Malign and Benign Breast Lesions’ at Eczacibasi Procter and Gamble Fund: ‘Breast Diseases Graduate Training Program’. April 1997.